Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction

Background— Nearly half of patients with heart failure have a preserved ejection fraction (HFpEF). Symptoms of exercise intolerance and dyspnea are most often attributed to diastolic dysfunction; however, impaired systolic and/or arterial vasodilator reserve under stress could also play an important role. Methods and Results— Patients with HFpEF (n=17) and control subjects without heart failure (n=19) generally matched for age, gender, hypertension, diabetes mellitus, obesity, and the presence of left ventricular hypertrophy underwent maximal-effort upright cycle ergometry with radionuclide ventriculography to determine rest and exercise cardiovascular function. Resting cardiovascular function was similar between the 2 groups. Both had limited exercise capacity, but this was more profoundly reduced in HFpEF patients (exercise duration 180±71 versus 455±184 seconds; peak oxygen consumption 9.0±3.4 versus 14.4±3.4 mL · kg−1 · min−1; both P<0.001). At matched low-level workload, HFpEF subjects displayed ≈40% less of an increase in heart rate and cardiac output and less systemic vasodilation (all P<0.05) despite a similar rise in end-diastolic volume, stroke volume, and contractility. Heart rate recovery after exercise was also significantly delayed in HFpEF patients. Exercise capacity correlated with the change in cardiac output, heart rate, and vascular resistance but not end-diastolic volume or stroke volume. Lung blood volume and plasma norepinephrine levels rose similarly with exercise in both groups. Conclusions— HFpEF patients have reduced chronotropic, vasodilator, and cardiac output reserve during exercise compared with matched subjects with hypertensive cardiac hypertrophy. These limitations cannot be ascribed to diastolic abnormalities per se and may provide novel therapeutic targets for interventions to improve exercise capacity in this disorder.

[1]  William A. Dafoe,et al.  Principles of Exercise Testing and Interpretation , 2007 .

[2]  D. Kass,et al.  Sildenafil Inhibits β-Adrenergic–Stimulated Cardiac Contractility in Humans , 2005 .

[3]  D. Kass,et al.  Age- and Gender-Related Ventricular-Vascular Stiffening: A Community-Based Study , 2005, Circulation.

[4]  G. Aurigemma,et al.  Left Ventricular Systolic Performance, Function, and Contractility in Patients With Diastolic Heart Failure , 2005, Circulation.

[5]  M. Redfield,et al.  Epidemiology of diastolic heart failure. , 2005, Progress in cardiovascular diseases.

[6]  G. Aurigemma,et al.  Diastolic heart failure , 2004 .

[7]  W. Gaasch,et al.  Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. , 2004, The New England journal of medicine.

[8]  L. Sleeper,et al.  Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. , 2004, Journal of the American College of Cardiology.

[9]  G. Aurigemma,et al.  Clinical practice. Diastolic heart failure. , 2004, The New England journal of medicine.

[10]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[11]  H. Krumholz,et al.  Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. , 2003, Journal of the American College of Cardiology.

[12]  G. D. Johnston,et al.  Functional Consequences of Endothelial Nitric Oxide Synthase Uncoupling in Congestive Cardiac Failure , 2003, Circulation.

[13]  D. Kass,et al.  Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations , 2003, Circulation.

[14]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[15]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[16]  W. Hundley,et al.  Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. , 2002, JAMA.

[17]  D. Brutsaert,et al.  New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. , 2002, Circulation.

[18]  Steven W. Lee,et al.  Progression of Systolic Abnormalities in Patients With “Isolated” Diastolic Heart Failure and Diastolic Dysfunction , 2002, Circulation.

[19]  M. Lauer,et al.  Heart-rate recovery immediately after exercise as a predictor of mortality. , 1999, The New England journal of medicine.

[20]  C. H. Chen,et al.  Ventricular pacing with premature excitation for treatment of hypertensive-cardiac hypertrophy with cavity-obliteration. , 1999, Circulation.

[21]  C. H. Chen,et al.  Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals. , 1999, Journal of the American College of Cardiology.

[22]  K. Bailey,et al.  Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. , 1998, Circulation.

[23]  I. Belenkie,et al.  Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. , 1995, Circulation.

[24]  J. Wilson,et al.  Dissociation between exertional symptoms and circulatory function in patients with heart failure. , 1995, Circulation.

[25]  J. Fleg,et al.  Effects of acute beta-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise. , 1994, Circulation.

[26]  D. Kass,et al.  Ventricular systolic assessment in patients with dilated cardiomyopathy by preload-adjusted maximal power. Validation and noninvasive application. , 1994, Circulation.

[27]  D. Goldstein,et al.  Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. , 1994, Journal of chromatography. B, Biomedical applications.

[28]  J. Hartikainen,et al.  Valsalva manoeuvre in the assessment of baroreflex sensitivity in patients with coronary artery disease. , 1993, European heart journal.

[29]  D. Kass,et al.  Diminished Contractile Response to Increased Heart Rate in Intact Human Left Ventricular Hypertrophy Systolic Versus Diastolic Determinants , 1993, Circulation.

[30]  D. Kass,et al.  Diastolic Compliance of Hypertrophied Ventricle Is Not Acutely Altered by Pharmacologic Agents Influencing Active Processes , 1993, Annals of Internal Medicine.

[31]  K. Bailey,et al.  Catecholamine Metabolic Pathways and Exercise Training: Plasma and Urine Catecholamines, Metabolic Enzymes, and Chromogranin‐A , 1991, Circulation.

[32]  D. Kitzman,et al.  Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. , 1991, Journal of the American College of Cardiology.

[33]  P. Poole‐Wilson,et al.  Pulmonary artery pressure and activities in chronic heart failure , 1990 .

[34]  P. Poole‐Wilson,et al.  Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. , 1990, Journal of the American College of Cardiology.

[35]  M. Higginbotham,et al.  Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. , 1989, Circulation.

[36]  M. Higginbotham,et al.  The ventilatory threshold: quantitative analysis of reproducibility and relation to arterial lactate concentration in normal subjects and in patients with chronic congestive heart failure. , 1988, The American journal of cardiology.

[37]  K P Brin,et al.  Arterial hemodynamics in human hypertension. , 1986, The Journal of clinical investigation.

[38]  P. Poole‐Wilson,et al.  Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. , 1986, British heart journal.

[39]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[40]  Michael V. Green,et al.  Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. , 1985, Circulation.

[41]  J. Wilson,et al.  Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. , 1984, Circulation.

[42]  J. Fleg,et al.  Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. , 1984, Circulation.

[43]  M. Wilén,et al.  Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. , 1984, The American journal of cardiology.

[44]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[45]  L. Becker,et al.  Measurement of Absolute Left Ventricular Volume From Gated Blood Pool Studies , 1982, Circulation.

[46]  R. Okada,et al.  Radionuclide-determined change in pulmonary blood volume with exercise. Improved sensitivity of multigated blood-pool scanning in detecting coronary-artery disease. , 1979, The New England journal of medicine.